Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Multi-centre, single arm, open label, 6 months, phase II study to evaluate the effect of
Ery-Dex in improving Central Nervous System (CNS) symptoms in patients with Ataxia
Teleangiectasia (AT). The study consists of a screening period (max duration of 30 days) and
a treatment period (duration 6 months).